USE OF GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120295849A1
SERIAL NO

13542285

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention describes the methods of using incretin mimetics such as GLP-1 receptor agonists, particularly exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CEDARS-SINAI MEDICAL CENTER8700 BEVERLY BLVD LOS ANGELES CA 90048

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Conklin, Jeffrey Los Angeles, US 15 1787
Pimentel, Mark Los Angeles, US 92 1986
Soffer, Edy E Los Angeles, US 8 245

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation